Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targretin combined with phototherapy in cutaneous T-cell lymphoma
jRCT2031210625Suspended
- Sponsor
- Minophagen Pharmaceutical Co., Ltd.
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bexarotene in cutaneous T-cell lymphoma (CTCL), sponsored by Minophagen Pharmaceutical Co., Ltd. Primary endpoint: Incidence of photosensitivity and similar skin adverse events. Started Feb 2022; status: suspended.
02
Drugs
bexarotene
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on jRCT2031210625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210625.